Literature DB >> 17487341

Pathogenesis of fulminant type 1 diabetes.

Akihisa Imagawa1, Toshiaki Hanafusa.   

Abstract

Fulminant type 1 diabetes is a new subtype of type 1 diabetes. The term was established in 2000. It is a syndrome characterized by a markedly rapid and almost complete destruction of pancreatic beta-cells. Several lines of evidence suggest that both genetic factors, such as human leukocyte antigen (HLA), and environmental factors, such as viral infection, contribute to the development of this disease. It is also suggested that autoimmune processes contribute less critically to fulminant type 1 diabetes than to classic type 1A diabetes. Based on the findings made to date, both viral infection and the subsequent immune reaction in genetically susceptible individuals cause beta-cell destruction and lead to fulminant type 1 diabetes.

Entities:  

Year:  2007        PMID: 17487341      PMCID: PMC1828286          DOI: 10.1900/RDS.2006.3.169

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


  42 in total

1.  HLA-DR-DQ haplotype in rapid-onset type 1 diabetes in Japanese.

Authors:  Tomoatsu Nakamura; Shoichiro Nagasaka; Ikuyo Kusaka; Toshimitsu Yatagai; Jianmei Yang; Shun Ishibashi
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

2.  A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group.

Authors:  A Imagawa; T Hanafusa; J Miyagawa; Y Matsuzawa
Journal:  N Engl J Med       Date:  2000-02-03       Impact factor: 91.245

3.  Thyrotrophin-binding inhibiting immunoglobulins (TBII) in subacute thyroiditis.

Authors:  G Wägar; T Mäkinen
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1983

4.  Amelioration of diabetes mellitus in partially depancreatized rats by poly(ADP-ribose) synthetase inhibitors. Evidence of islet B-cell regeneration.

Authors:  Y Yonemura; T Takashima; K Miwa; I Miyazaki; H Yamamoto; H Okamoto
Journal:  Diabetes       Date:  1984-04       Impact factor: 9.461

5.  Demonstration of two different processes of beta-cell regeneration in a new diabetic mouse model induced by selective perfusion of alloxan.

Authors:  M Waguri; K Yamamoto; J I Miyagawa; Y Tochino; K Yamamori; Y Kajimoto; H Nakajima; H Watada; I Yoshiuchi; N Itoh; A Imagawa; M Namba; M Kuwajima; Y Yamasaki; T Hanafusa; Y Matsuzawa
Journal:  Diabetes       Date:  1997-08       Impact factor: 9.461

6.  Association of HLA-DQ genotype in autoantibody-negative and rapid-onset type 1 diabetes.

Authors:  Shoichiro Tanaka; Tetsuro Kobayashi; Koji Nakanishi; Rikako Koyama; Minoru Okubo; Toshio Murase; Masato Odawara; Hidetoshi Inoko
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

Review 7.  A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence.

Authors:  A Imagawa; T Hanafusa; J Miyagawa; Y Matsuzawa
Journal:  Ann Med       Date:  2000-11       Impact factor: 4.709

8.  T lymphocyte response against pancreatic beta cell antigens in fulminant Type 1 diabetes.

Authors:  R Kotani; M Nagata; A Imagawa; H Moriyama; H Yasuda; J Miyagawa; T Hanafusa; K Yokono
Journal:  Diabetologia       Date:  2004-07-09       Impact factor: 10.122

9.  Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.

Authors:  N Itoh; T Hanafusa; A Miyazaki; J Miyagawa; K Yamagata; K Yamamoto; M Waguri; A Imagawa; S Tamura; M Inada
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Association of fulminant type 1 diabetes with pregnancy.

Authors:  I Shimizu; H Makino; H Osawa; E Kounoue; A Imagawa; T Hanafusa; E Kawasaki; Y Fujii
Journal:  Diabetes Res Clin Pract       Date:  2003-10       Impact factor: 5.602

View more
  15 in total

Review 1.  Fulminant type 1 diabetes in China: a case report and review of the literature.

Authors:  Yun-fei Feng; Mei-fen Yao; Qi Li; Yan Sun; Cheng-jiang Li; Jian-guo Shen
Journal:  J Zhejiang Univ Sci B       Date:  2010-11       Impact factor: 3.066

2.  Successful pharmaceutical-grade streptozotocin (STZ)-induced hyperglycemia in a conscious tethered baboon (Papio hamadryas) model.

Authors:  Patrice A Frost; Shuyuan Chen; Marguerite J Mezzles; Venkata Saroja Voruganti; Edna J Nava-Gonzalez; Hector E Arriaga-Cazares; Katy A Freed; Anthony G Comuzzie; Ralph A DeFronzo; Jack W Kent; Paul A Grayburn; Raul A Bastarrachea
Journal:  J Med Primatol       Date:  2015-06-30       Impact factor: 0.667

3.  Elevated pancreatic enzymes, IgM, soluble interleukin-2 receptor in anti-GADab(+) type 1 diabetes.

Authors:  Hidekatsu Yanai; Sumie Moriyama
Journal:  World J Diabetes       Date:  2011-05-15

4.  Genetic Basis of Type 1 Diabetes: Similarities and Differences between East and West.

Authors:  Hiroshi Ikegami; Shinsuke Noso; Naru Babaya; Yoshihisa Hiromine; Yumiko Kawabata
Journal:  Rev Diabet Stud       Date:  2008-08-10

5.  Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset.

Authors:  Y Kawabata; H Ikegami; T Awata; A Imagawa; T Maruyama; E Kawasaki; S Tanaka; A Shimada; H Osawa; T Kobayashi; T Hanafusa; K Tokunaga; H Makino
Journal:  Diabetologia       Date:  2009-10-08       Impact factor: 10.122

Review 6.  Modeling Type 1 Diabetes Using Pluripotent Stem Cell Technology.

Authors:  Kriti Joshi; Fergus Cameron; Swasti Tiwari; Stuart I Mannering; Andrew G Elefanty; Edouard G Stanley
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-01       Impact factor: 5.555

7.  Correlation of glycated albumin but not hemoglobin A1c with endogenous insulin secretion in fulminant type 1 diabetes mellitus.

Authors:  Masafumi Koga; Jun Murai; Hiroshi Saito; Soji Kasayama; Tetsuro Kobayashi; Akihisa Imagawa; Toshiaki Hanafusa
Journal:  J Diabetes Investig       Date:  2010-12-03       Impact factor: 4.232

8.  Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein-Barr virus that developed in the course of chemotherapy of multiple myeloma.

Authors:  Atsushi Fujiya; Hiroshi Ochiai; Toshihiro Mizukoshi; Atsushi Kiyota; Taiga Shibata; Atsushi Suzuki; Norimi Ohashi; Hiroshi Sobajima
Journal:  J Diabetes Investig       Date:  2010-12-03       Impact factor: 4.232

9.  An Unusual Case of Fulminant Type 1 Diabetes during the Second Trimester of Pregnancy.

Authors:  Tomohiro Okuda; Sadao Yamashita; Yoshio Ogino; Hisashi Kataoka; Jo Kitawaki
Journal:  Case Rep Obstet Gynecol       Date:  2014-08-11

10.  Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes.

Authors:  Toyoshi Endo; Soichi Takizawa; Shoichiro Tanaka; Masashi Takahashi; Hideki Fujii; Terumi Kamisawa; Tetsuro Kobayashi
Journal:  Diabetes       Date:  2008-11-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.